Lokken Investment Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.43M Buy
5,080
+184
+4% +$53.4K 0.49% 57
2025
Q2
$1.37M Buy
4,896
+400
+9% +$113K 0.53% 53
2025
Q1
$1.4M Buy
4,496
+375
+9% +$111K 0.59% 45
2024
Q4
$1.07M Buy
4,121
+85
+2% +$25.2K 0.46% 60
2024
Q3
$1.3M Buy
4,036
+294
+8% +$96.2K 0.54% 47
2024
Q2
$1.17M Buy
3,742
+449
+14% +$132K 0.55% 43
2024
Q1
$936K Buy
3,293
+178
+6% +$52.1K 0.47% 58
2023
Q4
$897K Buy
3,115
+2,158
+225% +$588K 0.51% 54
2023
Q3
$257K Buy
+957
New +$239K 0.17% 107

Other funds holding AMGN

Lokken Investment Group's AMGN Position: Q3 2025 in Review

Lokken Investment Group increased its Amgen (AMGN) stake by 3.8% in Q3 2025, buying an estimated $53.4K and bringing the position to 5,080 shares worth $1.43M. The position accounts for 0.49% of the portfolio, ranked #57.

Lokken Investment Group first reported a position in AMGN in Q3 2023 and has held it in 9 quarters since. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Lokken Investment Group held 5,080 shares of Amgen worth $1.43M as of Q3 2025.
  • Lokken Investment Group bought 184 Amgen shares in Q3 2025, an estimated $53.4K.
  • Amgen made up 0.49% of Lokken Investment Group's portfolio in Q3 2025, its #57 holding.
  • Lokken Investment Group first reported a position in Amgen in Q3 2023 and has held it in 9 quarters since.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Lokken Investment Group's 13F filing for Q3 2025, filed 5 Nov 2025.